Skip to main content

Healthcare Solutions

Looking beyond the ‘magic bullet’ approach to drug discovery

May. 1, 2018—Vanderbilt scientists have developed a new process that can rapidly and inexpensively identify personalized cancer drugs derived from nature.

Read more


‘Smart cane’ could one day help flag gait problems, falling risks more quickly

Feb. 12, 2018—Falling is no joke when you're a senior citizen or have other balance issues. Vanderbilt engineers are working on a 'smart cane' that could help physical therapists spot and treat problems sooner.

Read more


Vanderbilt signs licensing, research agreements to develop new approach to schizophrenia treatment

Jan. 8, 2018—Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia.

Read more


Study seeks to reduce opioid use for chronic pain

Nov. 30, 2017—Kristin Archer, PhD, DPT, associate professor and vice chair of Orthopaedics and Rehabilitation, will serve as principal investigator at Vanderbilt University Medical Center (VUMC) for a clinical trial that is examining strategies for reducing opioid use among patients with chronic pain.

Read more


Cell signals that trigger wound healing are surprisingly complex

Oct. 3, 2017—Vanderbilt scientists have taken an important step toward understanding the way in which injured cells trigger wound healing, an insight essential for improving treatments of all types of wounds.

Read more


Goal of new tissue-chip research is to assess efficacy of novel epilepsy drugs

Sep. 20, 2017—An interdisciplinary team of Vanderbilt University researchers has received a two-year, $2-million federal grant to develop an “organ-on-chip” model for two genetic forms of epilepsy.

Read more


VUSN and VUMC researchers receive FAANP funding for Choosing Wisely collaborative study

Aug. 14, 2017—A collaborative project between Vanderbilt University School of Nursing and Vanderbilt University Medical Center has received funding to pilot a project aimed at demonstrating the influence of nurse practitioners in reducing unnecessary testing.

Read more


Vanderbilt begins Phase 1 trials of new Alzheimer’s drug

Aug. 7, 2017—Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.

Read more


Smart underwear prevents back stress with just a tap

Aug. 1, 2017—"Performance-boosting super suit" hidden under clothing can be activated by a double tap to save users' backs.

Read more


How six cups of ground coffee can improve nose, throat surgery

Jun. 20, 2017—Vanderbilt engineers have designed a “granular jamming cap” filled with coffee grounds that can improve the accuracy of the sophisticated “GPS” system that surgeons use for nose and throat surgery.

Read more


Risky business

Apr. 5, 2017—Vanderbilt investigators have developed hospital readmission models that may help prevent payment penalties to hospitals when patients are readmitted too soon after discharge.

Read more


Vanderbilt investigator lands Stand Up To Cancer grant for “smart” nanoparticles cancer research

Apr. 3, 2017—John Wilson, Ph.D., assistant professor of Chemical and Biomolecular Engineering and of Biomedical Engineering at Vanderbilt University, has received an Innovative Research Grant from Stand Up To Cancer (SU2C). Wilson is among 10 early-career scientists to receive the grant awards focused on immuno-oncology.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more